These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7209360)

  • 1. Additional antitumoral effects of bromocriptine and radiotherapy in patients with prolactinomas or acromegaly.
    Coculescu M; Alessandrescu D; Stoica T; Simionescu N; Dimitriu V; Oprescu M; Chelmu S; Urba-Navicius V; Isbăşoiu O
    Endocrinologie; 1980; 18(4):277-88. PubMed ID: 7209360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
    Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hormonal effects of pituitary surgery and irradiation: a review of 59 cases.
    Wittert G; Donald RA; Espiner EA; Livesey JH; Fox H
    N Z Med J; 1985 Feb; 98(773):93-7. PubMed ID: 2983273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Follow-up of patients with pituitary tumors before and after operation, medical treatment and radiotherapy (author's transl)].
    Gasser RW; Finkenstedt G; Skrabal F
    Acta Med Austriaca; 1981; 8(4):112-20. PubMed ID: 7315152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of hyperprolactinemia on glucose disposal and insulin secretion in patients with prolactinomas.
    Katz EJ; Donald RA; Beaven DW; Espiner EA
    Horm Metab Res; 1981 Dec; 13(12):667-9. PubMed ID: 7033092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant invasive prolactinoma: a case report and review of nine further cases.
    Davis JR; Sheppard MC; Heath DA
    Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin secreting adenoma in 22 men.
    Grisoli F; Vincentelli F; Jaquet P; Guibout M; Hassoun J; Farnarier P
    Surg Neurol; 1980 Apr; 13(4):241-7. PubMed ID: 7376059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin and placental hormone levels during pregnancy in prolactinomas.
    Batrinos ML; Panitsa-Faflia C; Anapliotou M; Pitoulis S
    Int J Fertil; 1981; 26(2):77-85. PubMed ID: 6114069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug and radiotherapy of pituitary tumors].
    Yoshida H; Takeda F; Kinouchi T; Shimizu N
    Nihon Rinsho; 1986 Mar; 44(3):659-66. PubMed ID: 3016373
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of acromegaly.
    Lamberts SW; Klijn JG; De Lange SA; Birkenhäger JC
    Neth J Med; 1979; 22(5):161-6. PubMed ID: 388245
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypothalamic-pituitary function following bromocriptine therapy in patients with prolactinomas.
    Badawy SZ; Notman DD; Sunderlin FS; Springer JM; Streeten DH; Omar MM; Marshall LD
    J Reprod Med; 1982 Mar; 27(3):139-45. PubMed ID: 6806469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
    Lloyd HM; Jacobi JM; Willgoss DA
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine in the medical management of acromegaly.
    Besser GM; Wass JA; Thorner MO
    Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
    [No Abstract]   [Full Text] [Related]  

  • 17. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal evidence for the dissemination through the cerebrospinal fluid, of secreting cells from invasive pituitary adenomas.
    Coculescu M; Temel E; Oprescu M; Constantinovici A; Carp N; Simiónescu N
    Endocrinologie; 1981; 19(2):129-35. PubMed ID: 7256167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
    Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.